Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05041374 · ClinicalTrials.gov registry record
Evaluation of Patients With Gastrointestinal Disease
A clinical trial of Gastrointestinal Diseases and Lower GI Disease, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Recruiting
- Registry status
- 4,000
- Enrollment target
- 1
- Study location
NCT05041374: Recruiting study of Gastrointestinal Diseases and Lower GI Disease, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
NCT05041374 is a study of Gastrointestinal Diseases and Lower GI Disease that is actively recruiting participants, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 4,000 participants, below the 36,131-participant average among 14 other Gastrointestinal Diseases trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05041374, a study of Gastrointestinal Diseases and Lower GI Disease, is actively recruiting participants, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- RECRUITING
- Registry status
- 4,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: Ongoing and future research projects that study gastrointestinal diseases depend on access to biological samples and clinical data. Researchers want to study people who are seen and treated for these diseases. This may help them assess and treat these diseases better in the future. Objective: To collect data and samples from people being seen and/or treated for gastrointestinal problems at NIH, to use in future research. Eligibility: Adults aged 18 and older who have known or suspected gastrointestinal disorders or need screening, treatment, or follow-up per current medical guidelines. Design: Participants will be screened with a physical exam. Their medical records will be reviewed. Participants will be seen by doctors based on the ailment they have. Their condition will be treated just like it would at a doctor s office. But the data and samples collected will be used for future research. Participants may give blood, urine, and/or stool samples. If participants have an endoscopy or colonoscopy as part of their standard care and samples are taken, they may be asked to give their leftover samples to NIH. Or, they may be asked to have extra samples taken for NIH to use. These samples may include gastric acid and/or tissue from the lining of the stomach or intestines. If samples are not taken as part of their standard care, they may be asked to have samples taken for NIH to use. Data will be stored at NIH. The data systems are password protected. Samples will be coded. Participants will take part in the study for as long as they agree to be seen for their disease....
Primary Outcome
Development of a data set comprised of results and observations obtained during standard clinical care of patients with known or suspected gastrointestinal disease and collection of samples to be used for future research.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2022-01-04 |
| Est. Completion | 2035-12-31 |
What NCT05041374 shows while recruiting
NCT05041374 is an observational study that tracks outcomes without assigning an intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus, below the 36,131-participant average among 14 other Gastrointestinal Diseases trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Gastrointestinal Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT05041374 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT05041374 about?
NCT05041374 is a clinical study titled "Evaluation of Patients With Gastrointestinal Disease". Background: Ongoing and future research projects that study gastrointestinal diseases depend on access to biological samples and clinical data. Researchers want to study people who are seen and treated for these diseases. This may help them assess and treat these diseases better in the future. Obj...
What is the current status of trial NCT05041374?
This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 2022-01-04. Estimated completion is 2035-12-31.
What conditions does trial NCT05041374 study?
This clinical trial studies the following conditions: Gastrointestinal Diseases, Lower GI Disease.
Who is sponsoring clinical trial NCT05041374?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05041374 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastrointestinal Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05041374's enrollment target sits among peer trials
4,000 2nd of 14 the highest of 14 other Gastrointestinal Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gastrointestinal Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
RECRUITING · Phase 1
-
Foregut Leaks-Role of Microbiome
RECRUITING · NA
-
Trans-nasal Endoscopy for Bariatric Patients
RECRUITING · NA
-
Virtual Reality for Non-cardiac Chest Pain
RECRUITING · NA
-
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RECRUITING · Phase 3
-
Immune Responses to Gluten
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI